Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.89 |
| ▸ | MAPT | P10636 | 4/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | HPGD | P15428 | 1/20 | 0.81 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.70 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.70 |
| ▸ | RELA | Q04206 | 2/20 | 0.70 |
| ▸ | NPC1 | O15118 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3402747 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL6799776 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL135491 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL2939266 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL10460555 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL22092312 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL9717064 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL4275232 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL589021 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A | |
| SCHEMBL9717062 | 1.00 | LMNA (1.00) | LMNAL3MBTL1MAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| US-20250268841-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2025-08-28 | — | — | US | claimed |
| WO-2025150056-A1 | A HERBAL VAGINAL OIL IN WATER EMULSION GEL LUBRICANT AND METHOD OF PREPARATION THEREOF | WAGHODE, Parag (IN) | 2025-07-17 | — | — | WO | claimed |
| US-20250120907-A1 | Transmucosal Drug Delivery System | Masiz, John J. (US) | 2025-04-17 | — | — | US | claimed |
| US-12246098-B2 | Trans-epithelial membrane drug delivery system | BioPhysics Pharma, Inc. (US) | 2025-03-11 | — | — | US | claimed |
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| US-20240216292-A1 | Trans-Epithelial Membrane Drug Delivery System | Masiz, John J. (US) | 2024-07-04 | — | — | US | claimed |
| US-20240108588-A1 | Transdermal Drug Delivery System | Masiz, John J. (US) | 2024-04-04 | — | — | US | claimed |
| US-11865217-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2024-01-09 | — | — | US | claimed |
| EP-3419588-B1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC (US) | 2023-04-05 | — | — | EP | claimed |
| EP-1076549-B1 | USE OF METALLOPROTINEASE INHIBITORS FOR INDUCING AND/OR STIMULATING GROWTH OF HAIR OR HAIRS AND/OR FOR SLOWING DOWN THEIR LOSS | OREAL (FR) | 2004-09-15 | — | — | EP | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| CN-1331967-A | Powder cosmetics and/or make-up and care composition containing specific adhesive | OREAL (FR) | 2002-01-23 | — | — | CN | claimed |
| US-5658576-A | Method for combatting cellulitis or reducing localized fatty excesses | L'OREAL (FR) | 1997-08-19 | — | — | US | claimed |
| US-5571503-A | AQUEOUS EMULSION, PLANT EXTRACTS, PHOSPHOLIPIDS, FREE RADICAL SCAVENGERS | CHANEL, INC. | 1996-11-05 | — | — | US | claimed |
| EP-0655235-B1 | Slimming composition | OREAL (FR) | 1996-08-07 | — | — | EP | claimed |
| EP-0371844-B1 | USE OF ALPHA-TOCOPHEROL, BENZYL, XANTHINOL OR HEXYL NICOTINATE OR ALPHA TOCOPHEROL ACETATE IN A COSMETIC OR PHARMACEUTICAL SLIMMING COMPOSITION | L'OREAL (FR) | 1992-07-29 | — | — | EP | claimed |
| EP-0220825-B1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION | DIOMED DEVELOPMENTS LIMITED (GB) | 1989-09-06 | — | — | EP | claimed |
| US-4690818-A | HAIR AND SKIN; CONTAIN COCODIMONIUM HYDROLYZED KERATIN AND MIXTURE OF MONO- AND DI-SACCHARIDES | CHARLES OF THE RITZ GROUP LTD. (US) | 1987-09-01 | — | — | US | claimed |
| EP-0220825-A2 | Pharmaceutical composition for topical application | DIOMED DEVELOPMENTS LIMITED (GB) | 1987-05-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605345-B2 | Transdermal drug delivery system | FABP2, VEGFA, CUTA | LMNA 512/4885L3MBTL1 3949/4885MAPT 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.